Natural Product Sciences

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지

Simultaneous Determination of Six Components in the Traditional Herbal Medicine 'Oryeongsan' by HPLC-DAD and LC-MS/MS

  • Lee, Jiwoo (Department of Biomaterials Engineering, Division of Bioscience and Biotechnology, Kangwon National University) ;
  • Weon, Jin Bae (Department of Biomaterials Engineering, Division of Bioscience and Biotechnology, Kangwon National University) ;
  • Lee, Bohyoung (Department of Biomaterials Engineering, Division of Bioscience and Biotechnology, Kangwon National University) ;
  • Yun, Bo-Ra (Department of Biomaterials Engineering, Division of Bioscience and Biotechnology, Kangwon National University) ;
  • Eom, Min Rye (Department of Biomaterials Engineering, Division of Bioscience and Biotechnology, Kangwon National University) ;
  • Ma, Choong Je (Department of Biomaterials Engineering, Division of Bioscience and Biotechnology, Kangwon National University)
  • Received : 2013.01.27
  • Accepted : 2013.03.06
  • Published : 2013.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

A simple high performance liquid chromatography - diode array detector (HPLC-DAD) method has been developed and validated for simultaneous determination of the six components (cinnamic acid, cinnamaldehyde, eugenol, atractylenolide I, atractylenolide III, and ergosterol) in Oryeongsan. In addition, identification of six marker compounds was conducted by a LC-MS/MS analysis. The six compounds in Oryeongsan were separated on Shishedo $C_{18}$ column (5 ${\mu}m$, $4.6{\times}250$ mm) at a column temperature of $30^{\circ}C$. The mobile phase was a mixture of 0.1% trifluoroacetic acid (TFA) water and acetonitrile employing gradient elution at a flow rate of 1.0 mL/min. The detection wavelength was set at 205, 250, 280, and 330 nm. The developed method had good linearity ($R^2$ > 0.9997) and the limit of detection (LOD) and limit of quantification (LOQ) were observed within the ranges 0.01~0.15 and 0.05~0.45 ${\mu}g/mL$, respectively. The relative standard deviation (RSD) values of intra- and inter-day testing were indicated that less than 3% and 90.31~103.31% of accuracy. The results of recovery test were 90.56~106.72% and RSD range was measured from 0.84 to 2.95%. In conclusion, this HPLC-DAD method has been successfully applied to the simultaneous determination of six compounds in Oryeongsan samples.

Keywords

References

  1. Ahn, Y.M., Cho, K.W., Kang, D.G., and Lee, H.S., Oryeongsan (Wulingsan), a traditional Chinese herbal medicine, induces natriuresis and diuresis along with an inhibition of the rennin-angiotensinaldosterone system in rats. J. Ethnopharmacol. 141, 780-785 (2012). https://doi.org/10.1016/j.jep.2012.02.021
  2. Chan, K., Progress in traditional Chinese medicine. Trends in Pharmacol. Sci. 16, 182-187 (1995). https://doi.org/10.1016/S0165-6147(00)89019-7
  3. He, L., Rong, X., Jiang, J.M., Liu, P.Q., and Li, Y., Amelioration of anticancer agent adriamycin-induced nephritic syndrome in rats by Wulingsan (Gorei-San), a blended traditional Chinese herbal medicine. Food Chem. Toxicol. 46, 1452-1460 (2008). https://doi.org/10.1016/j.fct.2007.12.005
  4. Jiang, W.Y., Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Trends in Pharmacol. Sci. 26, 558- 563 (2005). https://doi.org/10.1016/j.tips.2005.09.006
  5. Kiga, C., Goto, H., Sakurai, H., Hayashi, K., Hikiami, H., Shimada, Y., and Saiki, I., Effects of traditional Japanese (Kampo) medicines (orengedokuto, goreisan and shichimotsukokato) on the onset of stroke and expression patterns of plasma proteins in spontaneously hypertensive stroke-prone rats. J. Trad. Med. 25, 125-132 (2008).
  6. Liu, I.M., Tzeng, T.F., Liou, S.S., and Chang, C.J., The amelioration of streptozotocin diabetes-induced renal damage by Wu-Ling-San (hoelen five herb formula), a traditional Chinese prescription. J. Ethnopharmcol. 124, 211-218 (2009). https://doi.org/10.1016/j.jep.2009.04.021
  7. Li, Y., Jiang, J., and Zhao, C.J., Determination of ergosterol and cinnamaldehyde in Wulingsan by HPLC. Strait Pharm. J. 23, 58-60 (2011).
  8. Li, Y., Pan, X., Xiao, J., Chen, Y., and Chen, J., Determination of alisol A 24-acetate and alisol B 23-acetate in Wulingsan by HPLC-ELSD. Chin. Pharm. J. 42, 1499-1501 (2007).
  9. Liang, Y.Z., Xie, P., and Chan, K., Quality control of herbal medicines. J.Chromatogr. B. 812, 53-70 (2004). https://doi.org/10.1016/j.jchromb.2004.08.041
  10. Normile, D., The new face of traditional Chinese medicine. Science. 299, 188-190 (2003). https://doi.org/10.1126/science.299.5604.188
  11. Tsai, C.H., Chen, Y.C., Chen, L.D., Pan, T.C., Ho, C.Y., Lai, M.T., Tsai, F.J., and Chen, W.C., A traditional Chinese herbal antilithic formula, Wulingsan, effectively prevents the renal deposition of calcium oxalate crystal in ethylene glycol-fed rats. Urol. Res. 36, 17-24 (2008). https://doi.org/10.1007/s00240-007-0122-4
  12. Weon, J.B., Yang, H.J., Ma, J.Y., and Ma, C.J., Simultaneous determination of six active components in traditional herbal medicine 'Oyaksungisan' by HPLC-DAD. J. Nat. Med. 66, 510-515 (2012). https://doi.org/10.1007/s11418-011-0617-8
  13. Xie, J., Wang, W., Zhang, Y., Bai, Y., and Yang, Q., Simultaneous analysis of glycyrrhizin, paeoniflorin, quercetin, ferulic acid, liquiritin, formononetin, benzoic acid, and isoliquiritigenin in the Chinese proprietary medicine Xiao Yao Wan by HPLC. J. Pharm. Biomed. Anal. 45, 450-455 (2007). https://doi.org/10.1016/j.jpba.2007.07.011
  14. Yi, L., Qi, L.W., Li, P., Ma, Y.H., Luo, Y.J., and Li, H.Y., Simultaneous determination of bioactive constituents in Danggui Buxue Tang for quality control by HPLC coupled with a diode array detector, an evaporative light scattering detector and mass spectrometry. Anal. Bioanal. Chem. 389, 571-580 (2007). https://doi.org/10.1007/s00216-007-1431-8
  15. Yang, X.X., Zhang, X.X., Chang, R.M., Wang, Y.W., and Li, X.N., Simultaneous quantification of five major active components in capsules of the traditional Chinese medicine 'Shu-Jin-Zhi-Tong' by high performance liquid chromatography. J. Pharm. Anal. 1, 284-290 (2011). https://doi.org/10.1016/j.jpha.2011.08.002